Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNF114 | Q9Y508 | 3/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.54 |
| ▸ | BRD4 | O60885 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 13/20 | 0.38 |
| ▸ | USP2 | O75604 | 6/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.33 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nimbolide SCHEMBL26312156 | 1.00 | RNF114 (1.00) | RNF114HSP90AA1BRD4CYP3A4USP2 | |
| Nimbolide SCHEMBL23483973 | 1.00 | RNF114 (1.00) | RNF114HSP90AA1BRD4CYP3A4USP2 | |
| Nimbolide SCHEMBL26690496 | 1.00 | RNF114 (1.00) | RNF114HSP90AA1BRD4CYP3A4USP2 | |
| Nimbolide SCHEMBL21163877 | 1.00 | RNF114 (1.00) | RNF114HSP90AA1BRD4CYP3A4USP2 | |
| SCHEMBL26698833 | 0.93 | RNF114 (0.86) | RNF114HSP90AA1BRD4CYP3A4USP2 | |
| SCHEMBL24076795 | 0.92 | RNF114 (0.86) | RNF114HSP90AA1BRD4CYP3A4USP2 | |
| SCHEMBL24625130 | 0.90 | RNF114 (0.82) | RNF114HSP90AA1BRD4CYP3A4 | |
| SCHEMBL24076672 | 0.88 | RNF114 (0.78) | RNF114HSP90AA1BRD4 | |
| SCHEMBL24625481 | 0.88 | RNF114 (0.78) | RNF114HSP90AA1BRD4 | |
| SCHEMBL24076520 | 0.86 | RNF114 (0.76) | RNF114HSP90AA1BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102453-A1 | NEEM TREE LEAVES EXTRACT | VORDERWUELBECKE LAURENZ (DE) | 2026-04-16 | — | — | US | claimed |
| US-20260048131-A1 | BIFUNCTIONAL COMPOUNDS AND USES THEREOF | RISEN SUZHOU PHARMA TECH CO LTD (CN) | 2026-02-19 | — | — | US | claimed |
| EP-4630422-A1 | BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2025-10-15 | — | — | EP | claimed |
| EP-4590316-A1 | NEEM TREE LEAVES EXTRACT | Vorderwülbecke, Laurenz (DE) | 2025-07-30 | — | — | EP | claimed |
| EP-4587446-A1 | BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2025-07-23 | — | — | EP | claimed |
| WO-2025063888-A1 | SURVIVIN-TARGETED COMPOUNDS | KANCURE PTE. LTD. (SG) | 2025-03-27 | — | — | WO | claimed |
| US-20250090490-A1 | Compositions of Azadirachta Indica and Methods of Treating Cancer | UNIV TEXAS (US) | 2025-03-20 | — | — | US | claimed |
| WO-2025007920-A1 | COMBINED DRUG FOR DEGRADING ESTROGEN RECEPTOR AND USE THEREOF | 海创药业股份有限公司 | 2025-01-09 | — | — | WO | claimed |
| CN-119258223-A | Combined medicine for degrading estrogen receptor and application thereof | 海创药业股份有限公司 | 2025-01-07 | — | — | CN | claimed |
| US-20240336622-A1 | NIMBOLIDE ANALOGS AND METHODS OF USE THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-10-10 | — | — | US | claimed |
| US-20200069636-A1 | PROCESS FOR PREPARATION OF CO2 EXTRACT OF AZADIRACHTA INDICA AND HERBAL COMPOSITIONS THEREOF FOR TREATMENT OF CANCERS | NISARGA BIOTECH PRIVATE LIMITED (IN) | 2020-03-05 | — | — | US | claimed |
| WO-2020047405-A1 | COMPOSITIONS OF AZADIRACHTA INDICA AND METHODS OF TREATING CANCER | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2020-03-05 | — | — | WO | claimed |
| US-20190211027-A1 | NIMBOLIDE ANALOGS AS ANTI-CANCER AGENTS AND PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2019-07-11 | — | — | US | claimed |
| US-20180255787-A1 | PEST CONTROL FORMULATIONS AND METHODS OF MAKING AND USING SAME | 0903608 B.C. LTD. (CA) | 2018-09-13 | — | — | US | claimed |
| WO-2016089977-A1 | SUBSTITUTED INDAZOLE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | CELGENE CORPORATION (US) | 2016-06-09 | — | — | WO | claimed |
| WO-2015035199-A1 | NEEM COMPOSITIONS USED FOR THE TREATMENT OF CANCER | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2015-03-12 | — | — | WO | claimed |
| US-20140242199-A1 | PEST CONTROL FORMULATIONS AND METHODS OF MAKING AND USING SAME | 0903608 B.C. LTD. (CA) | 2014-08-28 | — | — | US | claimed |
| EP-2763541-A1 | PEST CONTROL FORMULATIONS AND METHODS OF MAKING AND USING SAME | 0903608 B.C. Ltd. (CA) | 2014-08-13 | — | — | EP | claimed |
| CN-103974621-A | Pest control formulations and methods of making and using the same | 0903608 B C LTD | 2014-08-06 | — | — | CN | claimed |
| WO-2013050967-A1 | PEST CONTROL FORMULATIONS AND METHODS OF MAKING AND USING SAME | 0903608 B.C. LTD. (CA) | 2013-04-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180255787-A1 | PEST CONTROL FORMULATIONS AND METHODS OF MAKING AND USING SAME | ACHE, DDT, SGMS2 | RNF114 4225/4885HSP90AA1 2076/4885BRD4 4165/4885 |
| US-20260048131-A1 | BIFUNCTIONAL COMPOUNDS AND USES THEREOF | KRAS, MDM2, VHL | RNF114 84/4885HSP90AA1 2743/4885BRD4 1314/4885 |
| US-20200069636-A1 | PROCESS FOR PREPARATION OF CO2 EXTRACT OF AZADIRACHTA INDICA AND HERBAL COMPOSITIONS THEREOF FOR TREATMENT OF CANCERS | SCO2, SI, CYP1A2 | RNF114 2800/4885HSP90AA1 2721/4885BRD4 3493/4885 |
| US-20190211027-A1 | NIMBOLIDE ANALOGS AS ANTI-CANCER AGENTS AND PREPARATION THEREOF | CCND1, CBR3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | RNF114 1219/4885HSP90AA1 2582/4885BRD4 1642/4885 |
| US-20240336622-A1 | NIMBOLIDE ANALOGS AND METHODS OF USE THEREOF | PARP1, PARP11, PARP12 | RNF114 2576/4885HSP90AA1 2674/4885BRD4 196/4885 |
| US-20260102453-A1 | NEEM TREE LEAVES EXTRACT | NNT, NNMT, NPM1 | RNF114 3264/4885HSP90AA1 3770/4885BRD4 548/4885 |
| US-20140242199-A1 | PEST CONTROL FORMULATIONS AND METHODS OF MAKING AND USING SAME | ACHE, DDT, SGMS2 | RNF114 4225/4885HSP90AA1 2076/4885BRD4 4165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.